Cell Therapy News Volume 23.17 | May 16 2022

    0
    146







    2022-05-16 | CTN 23.17


    Cell Therapy News by STEMCELL Technologies
    Vol. 23.17 – 16 May, 2022
    TOP STORY

    Cytosine Base Editing Enables Quadruple-Edited Allogeneic CAR-T Cells for T-ALL

    Cytosine base editors installed C•G to T•A point mutations in T cells with between 90-99% efficiency to silence gene expression without creating double-stranded breaks, greatly reducing or eliminating undesired editing outcomes following multiplexed editing as compared to CRISPR-Cas9.
    [Blood]

    AbstractFull Article
    PUBLICATIONSRanked by the impact factor of the journal

    FasL Microgels Induce Immune Acceptance of Islet Allografts in Nonhuman Primates

    Investigators reported a strategy through which cotransplantation of allogeneic islets and streptavidin–FasL–presenting microgels to the omentum under transient rapamycin monotherapy resulted in robust glycemic control, sustained C-peptide levels, and graft survival in diabetic nonhuman primates for over six months.
    [Science Advances]

    Full Article

    Off-the-Shelf CAR Natural Killer Cells Secreting IL-15 Target Spike in Treating COVID-19

    Scientists showed engineering of NK cells to express soluble interleukin-15 for enhancing their survival and a CAR consisting of an extracellular domain of ACE2, targeting the spike protein of SARS-CoV-2.
    [Nature Communications]

    Full Article

    Locally Secreted BiTEs Complement CAR T Cells by Enhancing Killing of Antigen Heterogeneous Solid Tumors

    Scientists detected expression of tumor-associated epidermal growth factor receptor (EGFR), EGFR variant III, and interleukin-13 receptor alpha 2 on glioma tissues and cancer stem cells.
    [Molecular Therapy]

    Abstract

    Rescue of Behavioral and Electrophysiological Phenotypes in a Pitt-Hopkins Syndrome Mouse Model by Genetic Restoration of Tcf4 Expression

    Investigators performed proof-of-concept viral gene therapy experiments using a conditional Tcf4 mouse model of Pitt-Hopkins syndrome and found that postnatally reinstating Tcf4 expression in neurons improved anxiety-like behavior, activity levels, innate behaviors, and memory.
    [eLife]

    AbstractPress Release

    Reestablishment of Spermatogenesis after More than 20 Years of Cryopreservation of Rat Spermatogonial Stem Cells Reveals an Important Impact in Differentiation Capacity

    The authors demonstrated that rat spermatogonial stem cells frozen for more than 20 years can be transplanted into recipient mice and produce all differentiating germ cell types.
    [PLoS Biology]

    Full Article

    Conductive Nanocomposite Hydrogel and Mesenchymal Stem Cells for the Treatment of Myocardial Infarction and Non-Invasive Monitoring via Pet/Ct

    The combination of MSCs and the injectable conductive nanocomposite hydrogel offered a promising strategy for myocardial infarction treatment.
    [Journal of Nanobiotechnology]

    Full ArticleGraphical Abstract

    Adipose Mesenchymal Stem Cell-Based Tissue Engineering Mesh with Sustained bFGF Release to Enhance Tissue Repair

    Investigators used coaxial electrospinning technology to achieve local basic fibroblast growth factor release to promote regeneration. Adipose-derived stem cells were loaded to demonstrate their paracrine ability of immune regulation and angiogenesis.
    [Biomaterials Science]

    Abstract

    Mesh-Like Electrospun Membrane Loaded with Atorvastatin Facilitates Cutaneous Wound Healing by Promoting the Paracrine Function of Mesenchymal Stem Cells

    Scientists established a rat model of wound healing, applied atorvastatin -loaded mesh-like membranes seeded with bone marrow-derived MSCs on wounds, and assessed their efficacy for promoting wound healing.
    [Stem Cell Research & Therapy]

    Full Article

    Improved Outcomes of Single-Unit Cord Blood Transplantation for Acute Myeloid Leukemia by Killer Immunoglobulin-Like Receptor 2DL1-Ligand Mismatch

    To investigate their role in acute myeloid leukemia, mismatch of KIR2DL1, KIR3DL1, and KIR3DL2-ligand were retrospectively assessed in patients undergoing cord blood transplantation with GVHD prophylaxis comprising a calcineurin inhibitor plus methotrexate or mycophenolate mofetil.
    [Bone Marrow Transplantation]

    Abstract

    Trafficking and Persistence of Alloantigen-Specific Chimeric Antigen Receptor Regulatory T Cells in Cynomolgus Macaque

    The authors describe a culture system that massively expands CAR Tregs specific for the Bw6 alloantigen. In vitro, these Tregs suppressed in an antigen-specific manner without pro-inflammatory cytokine secretion or cytotoxicity.
    [Cell Reports Medicine]

    Full Article
    REVIEWS

    CAR T-Cell Therapy in Highly-Aggressive B-Cell Lymphoma: Emerging Biological and Clinical Insights

    As more experience with CAR T-cell approaches is examined, it is interesting to consider how both tumor-cell specific and microenvironment factors that define these highly aggressive subsets influence susceptibility to this approach.
    [Blood]

    Abstract

    Stem Cell Transplantation for Induction of Remission in Medically Refractory Crohn’s Disease

    Stem cell therapy (SCT) is an innovative treatment that has been recently used in Crohn’s disease (CD). The exact role of SCT in CD is still unclear.
    [Cochrane Database of Systematic Reviews]

    Abstract
    INDUSTRY AND POLICY NEWS

    University of Nottingham Partnership Part of £20M Investment in New Blood and Transplant Units

    The University of Nottingham is one of five research units across blood, organ, plasma, and stem cells launched by NHS Blood and Transplant.
    [The University of Nottingham]

    Press Release

    BC Researchers Launching Clinical Trial for First Genetically Engineered Stem Cell-Based Therapy for Type 1 Diabetes

    Researchers from the UBC Faculty of Medicine and Vancouver Coastal Health have received $1 million from Canada’s Stem Cell Network to conduct research and a clinical trial for one of the world’s first genetically engineered cell replacement therapies for type 1 diabetes.
    [The University of British Columbia]

    Press Release
    FEATURED EVENT

    Gene Therapy Development & Manufacturing

    13 – 14 June 2022
    London, England, United Kingdom

    > See All Events

    JOB OPPORTUNITIES

    Specialist – Cell Therapy Quality Assurance

    Bristol Myers Squibb – Devens, Massachusetts, United States

    Research Technologist – Bioengineering

    STEMCELL Technologies, Inc. – Vancouver, British Columbia, Canada

    Postdoctoral Fellow – Immuno-Oncology/Vascular Biology Research

    Johns Hopkins University School of Medicine – St. Petersburg, Florida, United States

    Postdoctoral Fellow – In Vitro Vascular Models

    European Molecular Biology Laboratory – Barcelona, Spain

    Postdoctoral Researcher – Molecular Tissue/Organ Regeneration

    Helmholtz Munich – München, Germany

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cell Therapy News Twitter